Neuroprotection by Ketamine: A Review of the Experimental and Clinical Evidence

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 1, 2010, Pages 131-142

  Hudetz, Judith A ^a   Pagel, Paul S ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

clinical; human; ischemia; ketamine; neurologic; neuroprotection; stroke

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROPOFOL;

ANESTHESIOLOGICAL TECHNIQUES; ARTIFICIAL VENTILATION; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN VASCULAR RESISTANCE; COGNITION; DRUG EFFECT; DRUG MECHANISM; EXCITOTOXICITY; HEART SURGERY; HUMAN; LOW DRUG DOSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY;

ANOXIA; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; CEREBROVASCULAR CIRCULATION; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; KETAMINE; NEUROPROTECTIVE AGENTS; RECEPTORS, N-METHYL-D-ASPARTATE; REPERFUSION INJURY; SURGICAL PROCEDURES, OPERATIVE;

EID: 74449088026     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.05.008     Document Type: Review

References (137)

1. Messick Jr. J.M., Casement B., Sharbrough F.W., et al. Correlation of regional cerebral blood flow (rCBF) with EEG changes during isoflurane anesthesia for carotid endarterectomy: critical rCBF. Anesthesiology 66 (1987) 344-349
2. Takeshita H., Okuda Y., and Sari A. The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology 36 (1972) 69-75
3. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 22 (1999) 391-397
4. Martin R.L., Lloyd H.G., and Cowan A.I. The early events of oxygen and glucose deprivation: setting the scene for neuronal death?. Trends Neurosci 17 (1994) 251-257
5. Katsura K., Kristian T., and Siesjo B.K. Energy metabolism, ion homeostasis, and cell damage in the brain. Biochem Soc Trans 22 (1994) 991-996
6. Meldrum B.S. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J Nutr 130 (2000) 1007S-1015S
7. Leist M., and Nicotera P. Apoptosis, excitotoxicity, and neuropathology. Exp Cell Res 239 (1998) 183-201
8. Prass K., and Dirnagl U. Glutamate antagonists in therapy of stroke. Restor Neurol Neurosci 13 (1998) 3-10
9. Himmelseher S., Pfenninger E., and Georgieff M. The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons. Anesth Analg 83 (1996) 505-512
10. O'Neill L.A., and Kaltschmidt C. NF-kappa B: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20 (1997) 252-258
11. Shen C., Nettleton D., Jiang M., et al. Roles of the HIF-1 hypoxia-inducible factor during hypoxia response in Caenorhabditis elegans. J Biol Chem 280 (2005) 20580-20588
12. Sakai T., Ichiyama T., Whitten C.W., et al. Ketamine suppresses endotoxin-induced NF-kappaB expression. Can J Anaesth 47 (2000) 1019-1024
13. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14 (1996) 649-683
14. del Zoppo G.J., Schmid-Schonbein G.W., Mori E., et al. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22 (1991) 1276-1283
15. Hudetz A.G., Oliver J.A., Wood J.D., et al. Leukocyte adhesion in pial cerebral venules after PMA stimulation and ischemia/reperfusion in vivo. Adv Exp Med Biol 411 (1997) 513-518
16. Hudetz A.G., Wood J.D., and Kampine J.P. Nitric oxide synthase inhibitor augments post-ischemic leukocyte adhesion in the cerebral microcirculation in vivo. Neurol Res 21 (1999) 378-384
17. Barone F.C., Arvin B., White R.F., et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28 (1997) 1233-1244
18. Himmelseher S., Pfenninger E., Kochs E., et al. S(+)-ketamine up-regulates neuronal regeneration associated proteins following glutamate injury in cultured rat hippocampal neurons. J Neurosurg Anesthesiol 12 (2000) 84-94
19. Gonzales J.M., Loeb A.L., Reichard P.S., et al. Ketamine inhibits glutamate-, N-methyl-D-aspartate-, and quisqualate-stimulated cGMP production in cultured cerebral neurons. Anesthesiology 82 (1995) 205-213
20. Orser B.A., Pennefather P.S., and MacDonald J.F. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology 86 (1997) 903-917
21. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14 (1991) 60-67
22. Proescholdt M., Heimann A., and Kempski O. Neuroprotection of S(+) ketamine isomer in global forebrain ischemia. Brain Res 904 (2001) 245-251
23. Engelhard K., Werner C., Eberspacher E., et al. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 96 (2003) 524-531
24. Kawasaki T., Ogata M., Kawasaki C., et al. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 89 (1999) 665-669
25. Szekely A., Heindl B., Zahler S., et al. S(+)-ketamine, but not R(-)-ketamine, reduces postischemic adherence of neutrophils in the coronary system of isolated guinea pig hearts. Anesth Analg 88 (1999) 1017-1024
26. Shapira Y., Artru A.A., and Lam A.M. Ketamine decreases cerebral infarct volume and improves neurological outcome following experimental head trauma in rats. J Neurosurg Anesthesiol 4 (1992) 231-240
27. Miyamoto E., Nakao S., Tomimoto H., et al. Ketamine attenuates hypocapnia-induced neuronal damage in the caudoputamen in a rat model of chronic cerebral hypoperfusion. Neurosci Lett 354 (2004) 26-29
28. Hoffman W.E., Pelligrino D., Werner C., et al. Ketamine decreases plasma catecholamines and improves outcome from incomplete cerebral ischemia in rats. Anesthesiology 76 (1992) 755-762
29. Church J., Zeman S., and Lodge D. The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. Anesthesiology 69 (1988) 702-709
30. Dawson B., Michenfelder J.D., and Theye R.A. Effects of ketamine on canine cerebral blood flow and metabolism: Modification by prior administration of thiopental. Anesth Analg 50 (1971) 443-447
31. Oren R.E., Rasool N.A., and Rubinstein E.H. Effect of ketamine on cerebral cortical blood flow and metabolism in rabbits. Stroke 18 (1987) 441-444
32. Cavazzuti M., Porro C.A., Biral G.P., et al. Ketamine effects on local cerebral blood flow and metabolism in the rat. J Cereb Blood Flow Metab 7 (1987) 806-811
33. Sakabe T.N. Effects of Anesthetic Agents and Other Drugs on Cerebral Blood Flow, Metabolism, and Intracranial Pressure (2001), Mosby, St Louis, MO
34. Schwedler M., Miletich D.J., and Albrecht R.F. Cerebral blood flow and metabolism following ketamine administration. Can Anaesth Soc J 29 (1982) 222-226
35. Akeson J., Bjorkman S., Messeter K., et al. Cerebral pharmacodynamics of anaesthetic and subanaesthetic doses of ketamine in the normoventilated pig. Acta Anaesthesiol Scand 37 (1993) 211-218
36. Corssen G., Miyasaka M., and Domino E.F. Changing concepts in pain control during surgery: Dissociative anesthesia with CI-581. A progress report. Anesth Analg 47 (1968) 746-759
37. Mori K., Kawamata M., Mitani H., et al. A neurophysiologic study of ketamine anesthesia in the cat. Anesthesiology 35 (1971) 373-383
38. Kayama Y., and Iwama K. The EEG, evoked potentials, and single-unit activity during ketamine anesthesia in cats. Anesthesiology 36 (1972) 316-328
39. Nimkoff L., Quinn C., Silver P., et al. The effects of intravenous anesthetics on intracranial pressure and cerebral perfusion pressure in two feline models of brain edema. J Crit Care 12 (1997) 132-136
40. Ohata H., Iida H., Nagase K., et al. The effects of topical and intravenous ketamine on cerebral arterioles in dogs receiving pentobarbital or isoflurane anesthesia. Anesth Analg 93 (2001) 697-702
41. Nagase K., Iida H., and Dohi S. Effects of ketamine on isoflurane- and sevoflurane-induced cerebral vasodilation in rabbits. J Neurosurg Anesthesiol 15 (2003) 98-103
42. Wendling W.W., Chen D., Daniels F.B., et al. The effects of N-methyl-D-aspartate agonists and antagonists on isolated bovine cerebral arteries. Anesth Analg 82 (1996) 264-268
43. Shakunaga K., Kojima S., Jomura K., et al. Ketamine suppresses the production and release of endothelin 1 from cultured bovine endothelial cells. Anesth Analg 86 (1998) 1098-1102
44. Nagase K., Iida H., and Dohi S. L-arginine and nitroglycerin restore hypercapnia-induced cerebral vasodilation in rabbits after its attenuation by ketamine. Anesth Analg 94 (2002) 954-958
45. Chi O.Z., Wei H.M., Klein S.L., et al. Effect of ketamine on heterogeneity of cerebral microregional venous O2 saturation in the rat. Anesth Analg 79 (1994) 860-866
46. Hardingham G.E., Fukunaga Y., and Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5 (2002) 405-414
47. Ikonomidou C., Bosch F., Miksa M., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283 (1999) 70-74
48. Hayashi H., Dikkes P., and Soriano S.G. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth 12 (2002) 770-774
49. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 23 (2003) 876-882
50. Scallet A.C., Schmued L.C., Slikker Jr. W., et al. Developmental neurotoxicity of ketamine: Morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci 81 (2004) 364-370
51. Jevtovic-Todorovic V., Benshoff N., and Olney J.W. Ketamine potentiates cerebrocortical damage induced by the common anaesthetic agent nitrous oxide in adult rats. Br J Pharmacol 130 (2000) 1692-1698
52. Jevtovic-Todorovic V., Wozniak D.F., Benshoff N.D., et al. A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide. Brain Res 895 (2001) 264-267
53. Nakao S., Miyamoto E., Masuzawa M., et al. Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors. Brain Res 926 (2002) 191-196
54. Olney J.W., Labruyere J., Wang G., et al. NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254 (1991) 1515-1518
55. Olney J.W., Labruyere J., and Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244 (1989) 1360-1362
56. Fix A.S., Horn J.W., Wightman K.A., et al. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex. Exp Neurol 123 (1993) 204-215
57. Corso T.D., Sesma M.A., Tenkova T.I., et al. Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res 752 (1997) 1-14
58. Farber N.B., Wozniak D.F., Price M.T., et al. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia?. Biol Psychiatry 38 (1995) 788-796
59. Wang C., Sadovova N., Fu X., et al. The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 132 (2005) 967-977
60. Wang C., Sadovova N., Hotchkiss C., et al. Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci 91 (2006) 192-201
61. Anand K.J., and Soriano S.G. Anesthetic agents and the immature brain: Are these toxic or therapeutic?. Anesthesiology 101 (2004) 527-530
62. Arundine M., and Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 61 (2004) 657-668
63. Kochs E., Werner C., Hoffman W.E., et al. Concurrent increases in brain electrical activity and intracranial blood flow velocity during low-dose ketamine anaesthesia. Can J Anaesth 38 (1991) 826-830
64. Langsjo J.W., Kaisti K.K., Aalto S., et al. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 99 (2003) 614-623
65. Vollenweider F.X., Leenders K.L., Oye I., et al. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 7 (1997) 25-38
66. Holcomb H.H., Lahti A.C., Medoff D.R., et al. Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology 25 (2001) 165-172
67. Martin W.R., Eades C.G., Thompson J.A., et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197 (1976) 517-532
68. Oye I., Hustveit O., Maurset A., et al. The ciral forms of ketamine as probes for NMDA-receptor function in humans. In: Kameyama T., Nabeshima T., and Domino E.F. (Eds). NMDA Receptor Related Agents (1991), NPP Books, Ann Arbor, MI
69. Debonnel G. Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry. J Psychiatry Neurosci 18 (1993) 157-172
70. Krystal J.H., Karper L.P., Seibyl J.P., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51 (1994) 199-214
71. Lahti A.C., Koffel B., LaPorte D., et al. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13 (1995) 9-19
72. Malhotra A.K., Pinals D.A., Weingartner H., et al. NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers. Neuropsychopharmacology 14 (1996) 301-307
73. Fox P.T., and Raichle M.E. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci U S A 83 (1986) 1140-1144
74. Fox P.T., Raichle M.E., Mintun M.A., et al. Nonoxidative glucose consumption during focal physiologic neural activity. Science 241 (1988) 462-464
75. Madson J.B.C. The Effects of Anesthetics Upon Cerebral Circulation and Metabolism: Experimental and Clinical Studies (1990), Springer, New York, NY
76. Wyte S.R., Shapiro H.M., Turner P., et al. Ketamine-induced intracranial hypertension. Anesthesiology 36 (1972) 174-176
77. Himmelseher S., and Durieux M.E. Revising a dogma: Ketamine for patients with neurological injury?. Anesth Analg 101 (2005) 524-534
78. Mayberg T.S., Lam A.M., Matta B.F., et al. Ketamine does not increase cerebral blood flow velocity or intracranial pressure during isoflurane/nitrous oxide anesthesia in patients undergoing craniotomy. Anesth Analg 81 (1995) 84-89
79. Albanese J., Arnaud S., Rey M., et al. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology 87 (1997) 1328-1334
80. Friesen R.H., Thieme R.E., Honda A.T., et al. Changes in anterior fontanel pressure in preterm neonates receiving isoflurane, halothane, fentanyl, or ketamine. Anesth Analg 66 (1987) 431-434
81. Kolenda H., Gremmelt A., Rading S., et al. Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir (Wien) 138 (1996) 1193-1199
82. Bourgoin A., Albanese J., Wereszczynski N., et al. Safety of sedation with ketamine in severe head injury patients: Comparison with sufentanil. Crit Care Med 31 (2003) 711-717
83. Nagase K., Iida H., Ohata H., et al. Ketamine, not propofol, attenuates cerebrovascular response to carbon dioxide in humans with isoflurane anesthesia. J Clin Anesth 13 (2001) 551-555
84. Strebel S., Kaufmann M., Maitre L., et al. Effects of ketamine on cerebral blood flow velocity in humans. Influence of pretreatment with midazolam or esmolol. Anaesthesia 50 (1995) 223-228
85. Sakai K., Cho S., Fukusaki M., et al. The effects of propofol with and without ketamine on human cerebral blood flow velocity and CO(2) response. Anesth Analg 90 (2000) 377-382
86. Engelhard K., Werner C., Mollenberg O., et al. S(+)-ketamine/propofol maintain dynamic cerebrovascular autoregulation in humans. Can J Anaesth 48 (2001) 1034-1039
87. Grathwohl K.W., Black I.H., Spinella P.C., et al. Total intravenous anesthesia including ketamine versus volatile gas anesthesia for combat-related operative traumatic brain injury. Anesthesiology 109 (2008) 44-53
88. Frizelle H.P., Duranteau J., and Samii K. A comparison of propofol with a propofol-ketamine combination for sedation during spinal anesthesia. Anesth Analg 84 (1997) 1318-1322
89. Furuya A., Matsukawa T., Ozaki M., et al. Intravenous ketamine attenuates arterial pressure changes during the induction of anaesthesia with propofol. Eur J Anaesthesiol 18 (2001) 88-92
90. Wong D.H., and Jenkins L.C. The cardiovascular effects of ketamine in hypotensive states. Can Anaesth Soc J 22 (1975) 339-348
91. Slogoff S., Girgis K.Z., and Keats A.S. Etiologic factors in neuropsychiatric complications associated with cardiopulmonary bypass. Anesth Analg 61 (1982) 903-911
92. Laffey J.G., Boylan J.F., and Cheng D.C. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 97 (2002) 215-252
93. Butler J., Rocker G.M., and Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55 (1993) 552-559
94. Zanetti G., Heumann D., Gerain J., et al. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. J Immunol 148 (1992) 1890-1897
95. Giroir B.P. Mediators of septic shock: New approaches for interrupting the endogenous inflammatory cascade. Crit Care Med 21 (1993) 780-789
96. Liesker J.J., Postma D.S., Beukema R.J., et al. Cognitive performance in patients with COPD. Respir Med 98 (2004) 351-356
97. Tonz M., Mihaljevic T., von Segesser L.K., et al. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible?. Chest 108 (1995) 1551-1556
98. Fountain S.W., Martin B.A., Musclow C.E., et al. Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits. Circ Res 46 (1980) 175-180
99. Bando K., Pillai R., Cameron D.E., et al. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg 99 (1990) 873-877
100. Havemann K., and Gramse M. Physiology and pathophysiology of neutral proteinases of human granulocytes. Adv Exp Med Biol 167 (1984) 1-20
101. Janoff A. Elastase in tissue injury. Annu Rev Med 36 (1985) 207-216
102. Riegel W., Spillner G., Schlosser V., et al. Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 95 (1988) 1014-1019
103. Butler J., Parker D., Pillai R., et al. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 105 (1993) 25-30
104. Finn A., Naik S., Klein N., et al. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 105 (1993) 234-241
105. Faymonville M.E., Pincemail J., Duchateau J., et al. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 102 (1991) 309-317
106. Zilberstein G., Levy R., Rachinsky M., et al. Ketamine attenuates neutrophil activation after cardiopulmonary bypass. Anesth Analg 95 (2002) 531-536
107. Roytblat L., Talmor D., Rachinsky M., et al. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg 87 (1998) 266-271
108. Cremer J., Martin M., Redl H., et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61 (1996) 1714-1720
109. Deng M.C., Dasch B., Erren M., et al. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann Thorac Surg 62 (1996) 184-190
110. Hennein H.A., Ebba H., Rodriguez J.L., et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108 (1994) 626-635
111. Kalman J., Juhasz A., Bogats G., et al. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochem Int 48 (2006) 177-180
112. Buvanendran A., Kroin J.S., Berger R.A., et al. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology 104 (2006) 403-410
113. Dantzer R., and Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21 (2007) 153-160
114. Bartoc C., Frumento R.J., Jalbout M., et al. A randomized, double-blind, placebo-controlled study assessing the anti-inflammatory effects of ketamine in cardiac surgical patients. J Cardiothorac Vasc Anesth 20 (2006) 217-222
115. Taylor N.M., Lacoumenta S., and Hall G.M. Fentanyl and the interleukin-6 response to surgery. Anaesthesia 52 (1997) 112-115
116. Smith F.J., Bartel P.R., Hugo J.M., et al. Anesthetic technique (sufentanil versus ketamine plus midazolam) and quantitative electroencephalographic changes after cardiac surgery. J Cardiothorac Vasc Anesth 20 (2006) 520-525
117. Tuman K.J., McCarthy R.J., Spiess B.D., et al. Does choice of anesthetic agent significantly affect outcome after coronary artery surgery?. Anesthesiology 70 (1989) 189-198
118. Nagels W., Demeyere R., Van Hemelrijck J., et al. Evaluation of the neuroprotective effects of S(+)-ketamine during open-heart surgery. Anesth Analg 98 (2004) 1595-1603
119. Marcantonio E.R., Juarez G., Goldman L., et al. The relationship of postoperative delirium with psychoactive medications. JAMA 272 (1994) 1518-1522
120. Dyer C.B., Ashton C.M., and Teasdale T.A. Postoperative delirium. A review of 80 primary data-collection studies. Arch Intern Med 155 (1995) 461-465
121. Moller J.T., Cluitmans P., Rasmussen L.S., et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 351 (1998) 857-861
122. Hudetz J.A., Iqbal Z., Gandhi S.D., et al. Ketamine attenuates postoperative cognitive dysfunction one week after cardiac surgery. Anesthesiology 109 (2008) A826
123. Hudetz J.A., Patterson K.M., Iqbal Z., et al. Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth (2009 Feb 19) [Epub ahead of print]
124. Greene N., Attix D., Macy S., et al. Preoperative Executive Function and Depression Predict Postoperaive Delirium (2008), American Society of Anesthesiologists, Orlando, FL A842
125. Rudolph J.L., Jones R.N., Levkoff S.E., et al. Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery. Circulation 119 (2008) 229-236
126. Stump D.A. Selection and clinical significance of neuropsychologic tests. Ann Thorac Surg 59 (1995) 1340-1344
127. Jones M.J., Piggott S.E., Vaughan R.S., et al. Cognitive and functional competence after anaesthesia in patients aged over 60: Controlled trial of general and regional anaesthesia for elective hip or knee replacement. BMJ 300 (1990) 1683-1687
128. Landro N.I., Stiles T.C., and Sletvold H. Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol 14 (2001) 233-240
129. Rose E.J., and Ebmeier K.P. Pattern of impaired working memory during major depression. J Affect Disord 90 (2006) 149-161
130. MacQueen G.M., Galway T.M., Hay J., et al. Recollection memory deficits in patients with major depressive disorder predicted by past depressions but not current mood state or treatment status. Psychol Med 32 (2002) 251-258
131. Taylor Tavares J.V., Clark L., Cannon D.M., et al. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biol Psychiatry 62 (2007) 917-924
132. Skolnick P., Layer R.T., Popik P., et al. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression. Pharmacopsychiatry 29 (1996) 23-26
133. Berman R.M., Cappiello A., Anand A., et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47 (2000) 351-354
134. Kudoh A., Takahira Y., Katagai H., et al. Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 95 (2002) 114-118
135. Newman M.F., Kirchner J.L., Phillips-Bute B., et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344 (2001) 395-402
136. Wilmore D.W., and Kehlet H. Management of patients in fast track surgery. BMJ 322 (2001) 473-476
137. Roach G.W., Kanchuger M., Mangano C.M., et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 335 (1996) 1857-1863